Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

BXBlackstone Inc.

NYSE · CIK 0001393818
Filer categoryLarge accelerated filer
Entity typeoperating
SIC6282 Investment Advice
FY end1231
XBRL facts432

Identity from submissions API

NameBlackstone Inc.
CIK0001393818
TickersBX
ExchangesNYSE
Entity typeoperating
CategoryLarge accelerated filer
SIC6282 Investment Advice
EIN—
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone(212) 583-5000
Website—
Investor website—
Owner org02 Finance
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)1

Former names

  • Blackstone Inc (2021-08-06T04:00:00.000Z → 2022-04-07T04:00:00.000Z)
  • Blackstone Group Inc (2019-07-01T04:00:00.000Z → 2021-08-05T04:00:00.000Z)
  • Blackstone Group L.P. (2007-03-22T04:00:00.000Z → 2019-06-28T04:00:00.000Z)
Business address
345 PARK AVENUE
NEW YORK
NY
10154
NY
Mailing address
345 PARK AVENUE
NEW YORK
NY
10154
NY

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

1757 filing rows loaded from submissions recent; extra archives: CIK0001393818-submissions-001.json (756 filings, 2007-03-22 to 2017-07-16).

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-19 4 4 0001193125-26-468658 001-43022 261575316 34 44398
2026-11-18 4 4 0001193125-26-467147 6585
2026-11-16 13F-HR xslForm13F_X02/primary_doc.xml 0001193125-26-463513 028-13114 261560836 34 222300
2026-11-16 13F-HR/A xslForm13F_X02/primary_doc.xml 0001193125-26-463479 028-13114 261560577 34 7485
2026-11-16 13F-HR/A xslForm13F_X02/primary_doc.xml 0001193125-26-463428 028-13114 261560392 34 5043
2026-11-16 13F-HR/A xslForm13F_X02/primary_doc.xml 0001193125-26-463420 028-13114 261560342 34 6934
2026-11-16 13F-HR/A xslForm13F_X02/primary_doc.xml 0001193125-26-463398 028-13114 261560109 34 5935
2026-11-13 4 4 0001193125-26-460700 12098
2026-11-12 4 4 0001193125-26-458686 8206
2026-11-10 4 4 0001193125-26-455577 001-41504 261540891 34 45808
2026-11-10 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001193125-26-455574 354460
2026-11-06 10-Q 10-Q 0001193125-26-451802 001-33551 261531781 34 30766684 1 1
2026-11-02 8-K 8-K 1.01,2.03,8.01,9.01 0001193125-26-443854 001-33551 261513381 34 822366 1 1
2026-10-30 4 4 0001193125-26-441717 11321
2026-10-29 424B5 424B5 0001193125-26-437754 333-283540 261501509 33 915338 1 1
2026-10-27 8-K 8-K 8.01,9.01 0001193125-26-434438 001-33551 261491451 34 148600 1 1
2026-10-27 FWP FWP 0001193125-26-434433 333-283540 261491392 34 26740
2026-10-27 8-K 8-K 8.01,9.01 0001193125-26-432970 001-33551 261487725 34 148199 1 1
2026-10-27 424B5 424B5 0001193125-26-432790 333-283540 261487421 33 724450
2026-10-23 4 xslF345X06/ownership.xml 0001213900-26-112119 814-01853 261482390 34 39662
2026-10-22 8-K 8-K 2.02,9.01 0001193125-26-428297 001-33551 261477165 34 3154955 1 1
2026-10-15 8-K 8-K 5.02 0001193125-26-422888 001-33551 261463200 34 132516 1 1
2026-10-14 4 4 0001193125-26-421998 001-40054 261461019 34 67693
2026-10-09 13F-HR/A xslForm13F_X02/primary_doc.xml 0001193125-26-419121 028-13114 261453061 34 5740
2026-10-09 13F-HR/A xslForm13F_X02/primary_doc.xml 0001193125-26-419098 028-13114 261453003 34 5239
2026-10-09 13F-HR/A xslForm13F_X02/primary_doc.xml 0001193125-26-419075 028-13114 261452918 34 5239
2026-10-07 3 3 0001193125-26-417100 000-56450 261447796 34 60517
2026-09-30 4 4 0001193125-26-409256 001-40054 261428062 34 68578
2026-09-28 4 4 0001193125-26-405400 001-43121 261417685 34 16463
2026-09-24 4 xslF345X06/ownership.xml 0001213900-26-103146 814-01853 261405883 34 38726
2026-09-22 8-K 8-K 7.01,9.01 0001193125-26-398100 001-33551 261397533 34 146544 1 1
2026-09-18 4 4 0001193125-26-395751 7080
2026-09-18 144 xsl144X01/primary_doc.xml 0001964306-26-000451 001-33551 261390810 33 5683
2026-08-28 N-PX xslN-PX_X01/primary_doc.xml 0001193125-26-374760 028-13114 261341508 34 572135
2026-08-26 4 4 0001193125-26-368713 001-43426 261323409 34 44356
2026-08-24 4 xslF345X06/ownership.xml 0001213900-26-093085 814-01853 261311174 34 38488
2026-08-24 4/A xslF345X06/ownership.xml 0001213900-26-093080 814-01853 261311124 34 37146
2026-08-14 13F-HR xslForm13F_X02/primary_doc.xml 0001193125-26-352211 028-13114 261281368 34 281624
2026-08-14 13F-HR/A xslForm13F_X02/primary_doc.xml 0001193125-26-352197 028-13114 261281162 34 6915
2026-08-14 13F-HR/A xslForm13F_X02/primary_doc.xml 0001193125-26-352142 028-13114 261280987 34 5930
2026-08-14 13F-HR/A xslForm13F_X02/primary_doc.xml 0001193125-26-352125 028-13114 261280762 34 5928
2026-08-13 4 4 0001193125-26-349583 001-41603 261274819 34 81451
2026-08-12 4 4 0001193125-26-347284 12698
2026-08-12 4 4 0001193125-26-347283 5261
2026-08-12 4 4 0001193125-26-347281 8207
2026-08-12 4 4 0001193125-26-347014 001-41504 261268232 34 46637
2026-08-11 144 xsl144X01/primary_doc.xml 0001964306-26-000380 001-33551 261263256 33 5674
2026-08-11 144 xsl144X01/primary_doc.xml 0001964306-26-000379 001-33551 261263239 33 5072
2026-08-07 10-Q 10-Q 0001193125-26-340208 001-33551 261253820 34 32527795 1 1
2026-08-06 4 4 0001193125-26-338213 001-41603 261249677 34 80768
2026-08-05 4 4 0001193125-26-335160 8276
2026-08-05 4 4 0001193125-26-335158 6929
2026-08-04 144 xsl144X01/primary_doc.xml 0001964306-26-000365 001-33551 261239487 33 4468
2026-08-04 4 4 0001193125-26-332966 001-43426 261239433 34 44154
2026-07-30 3 3 0001193125-26-326271 001-43426 261223931 34 54318
2026-07-24 4 xslF345X06/ownership.xml 0001213900-26-081436 814-01853 261202030 34 20411
2026-07-23 8-K 8-K 2.02,9.01 0001193125-26-313250 001-33551 261195161 34 3380706 1 1
2026-06-24 4 xslF345X06/ownership.xml 0001213900-26-071510 814-01853 261116238 34 20902
2026-06-23 8-K 8-K 7.01,9.01 0001193125-26-279498 001-33551 261111315 34 145948 1 1
2026-06-18 4 4 0001193125-26-276294 001-40054 261104600 34 66959
2026-06-04 3 3 0001193125-26-257512 001-43327 261065412 34 23069
2026-06-01 4 4 0001193125-26-251451 001-43022 261050987 34 27138
2026-05-26 4 4 0001193125-26-239438 001-43022 261020355 34 33001
2026-05-19 4 4 0001193125-26-230882 001-43291 26999306 34 19925
2026-05-15 13F-HR xslForm13F_X02/primary_doc.xml 0001193125-26-226672 028-13114 26987118 34 224653
2026-05-15 13F-HR/A xslForm13F_X02/primary_doc.xml 0001193125-26-226614 028-13114 26986873 34 7436
2026-05-15 13F-HR/A xslForm13F_X02/primary_doc.xml 0001193125-26-226590 028-13114 26986656 34 5943
2026-05-13 3 3 0001193125-26-222128 001-43291 26975011 34 17155
2026-05-13 4 4 0001193125-26-221785 8206
2026-05-12 4 4 0001193125-26-220232 001-43121 26970503 34 16165
2026-05-12 3 3 0001193125-26-220224 001-43121 26970484 34 15705
2026-05-08 10-Q 10-Q 0001193125-26-214609 001-33551 26958293 34 23253081 1 1
2026-05-01 4 4 0001193125-26-201508 8271
2026-05-01 144 xsl144X01/primary_doc.xml 0001964306-26-000215 001-33551 26932869 33 4471
2026-04-29 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002100119-26-000187 005-83050 26917503 34 7547
2026-04-23 8-K 8-K 2.02,9.01 0001193125-26-171788 001-33551 26885465 34 3240515 1 1
2026-04-09 4 4 0001193125-26-149867 001-42838 26852564 34 27527
2026-04-03 4 4 0001193125-26-142413 6099
2026-04-03 4 4 0001193125-26-142399 6205
2026-04-03 4 4 0001193125-26-142395 6077
2026-04-03 4 4 0001193125-26-142393 5084
2026-04-03 4 4 0001193125-26-142387 5544
2026-04-03 4 4 0001193125-26-142385 5515
2026-04-03 4 4 0001193125-26-142384 5586
2026-04-03 4 4 0001193125-26-142382 5575
2026-04-03 4 4 0001193125-26-142380 11129
2026-04-03 4 4 0001193125-26-142375 5069
2026-04-03 4 4 0001193125-26-142374 6978
2026-03-26 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000102909-26-000877 005-83050 26798963 34 7306
2026-03-24 8-K 8-K 7.01,9.01 0001193125-26-121857 001-33551 26786458 34 144835 1 1
2026-03-23 4 xslF345X06/ownership.xml 0001213900-26-032972 814-01853 26782949 34 24032
2026-03-19 4 4 0001193125-26-116399 001-40054 26775708 34 65554
2026-03-12 4 4 0001193125-26-104180 001-43022 26747912 34 26566
2026-03-12 4 4 0001193125-26-104169 11763
2026-03-06 4 4 0001193125-26-096827 001-43022 26731987 34 43840
2026-03-03 4 4 0001193125-26-089103 001-40308 26717646 34 38451
2026-02-27 S-8 S-8 0001193125-26-082899 333-293873 26700828 33 163372 1 1
2026-02-27 POSASR POSASR 0001193125-26-082622 333-283540 26699849 33 399703 1 1
2026-02-27 10-K 10-K 0001193125-26-082531 001-33551 26699647 34 36145317 1 1
2026-02-24 4 xslF345X05/ownership.xml 0001213900-26-020011 814-01853 26673466 34 23397
2026-02-20 4 4 0001193125-26-061364 8069
2026-02-17 13F-HR xslForm13F_X02/primary_doc.xml 0001193125-26-054623 028-13114 26641191 34 137373
2026-02-13 4 4 0001193125-26-051581 12391
2026-01-29 8-K 8-K 2.02,9.01 0001193125-26-028145 001-33551 26574647 34 3155281 1 1
2026-01-14 4 4 0001193125-26-012992 5231
2026-01-14 4 4 0001193125-26-012990 6306
2026-01-14 4 4 0001193125-26-012988 9007
2026-01-14 4 4 0001193125-26-012987 5204
2026-01-14 4 4 0001193125-26-012986 5246
2026-01-14 4 4 0001193125-26-012984 5175
2026-01-08 4 4 0001193125-26-007718 001-42838 26519778 34 26985
2025-12-22 4 xslF345X05/ownership.xml 0001213900-25-124629 814-01853 251593184 34 23405
2025-12-22 4 4 0001193125-25-328815 001-43022 251592844 34 31550
2025-12-17 3 3 0001193125-25-323234 001-43022 251580831 34 26492
2025-12-16 4 4 0001193125-25-320840 001-42838 251575173 34 26979
2025-12-12 4 4 0001193125-25-317635 9541
2025-12-12 4 4 0001193125-25-317634 9458
2025-12-08 4 4 0001193125-25-311548 001-40308 251557234 34 34929
2025-11-24 4 xslF345X05/ownership.xml 0001213900-25-114198 814-01853 251514033 34 23405
2025-11-14 13F-HR xslForm13F_X02/primary_doc.xml 0001193125-25-282864 028-13114 251485522 34 137682
2025-11-13 4 4 0001193125-25-280537 8113
2025-11-12 4 4 0001193125-25-277805 8102
2025-11-07 10-Q 10-Q 0001193125-25-272343 001-33551 251462722 34 28963023 1 1
2025-11-05 4 4 0001193125-25-267257 001-40054 251455149 34 53895
2025-11-05 4 4 0001193125-25-267167 6955
2025-11-03 8-K 8-K 1.01,2.03,8.01,9.01 0001193125-25-262626 001-33551 251444504 34 828522 1 1
2025-10-31 4 4 0001193125-25-261005 5052
2025-10-30 424B5 424B5 0001193125-25-258584 333-283540 251435828 33 866724 1 1
2025-10-28 8-K 8-K 8.01,9.01 0001193125-25-253885 001-33551 251425931 34 147120 1 1
2025-10-28 FWP FWP 0001193125-25-253882 333-283540 251425922 34 26799
2025-10-28 8-K 8-K 8.01,9.01 0001193125-25-252448 001-33551 251421624 34 145047 1 1
2025-10-28 424B5 424B5 0001193125-25-252423 333-283540 251421547 33 682278
2025-10-23 8-K/A 8-K/A 2.02,9.01 0001193125-25-248907 001-33551 251413809 34 3646652 1 1
2025-10-23 8-K 8-K 2.02,9.01 0001193125-25-247643 001-33551 251411344 34 3638629 1 1
2025-10-21 4 xslF345X05/ownership.xml 0001213900-25-100922 814-01853 251408168 34 23406
2025-10-17 8-K 8-K 1.01,2.03,9.01 0001193125-25-242655 001-33551 251401646 34 970713 1 1
2025-09-26 4 4 0001193125-25-220808 6943
2025-09-25 144 xsl144X01/primary_doc.xml 0001964306-25-000366 001-33551 251343694 33 4466
2025-09-24 8-K 8-K 7.01,9.01 0001193125-25-215457 001-33551 251338658 34 145122 1 1
2025-09-22 4 xslF345X05/ownership.xml 0001213900-25-090224 814-01853 251331127 34 19287
2025-09-17 4 4 0001193125-25-206314 14404
2025-09-11 3 3 0001193125-25-201581 001-42838 251309924 34 17846
2025-09-10 4 4 0001500278-25-000005 9819
2025-09-08 144 xsl144X01/primary_doc.xml 0001964306-25-000353 001-33551 251300019 33 5063
2025-09-05 4 4 0001510762-25-000004 9541
2025-09-05 4 4 0001574706-25-000004 9458
2025-08-29 N-PX xslN-PX_X01/primary_doc.xml 0001021408-25-004656 028-13114 251280704 34 113741
2025-08-22 4 xslF345X05/ownership.xml 0001213900-25-079912 000-56726 251246437 34 19287
2025-08-21 4 4 0000950170-25-110674 001-41585 251241141 34 36237
2025-08-15 4 4 0000950170-25-109496 001-40054 251225965 34 76957
2025-08-15 4 4 0000950170-25-109446 9962
2025-08-14 144 xsl144X01/primary_doc.xml 0001964306-25-000322 001-33551 251221288 33 5069
2025-08-14 13F-HR xslForm13F_X02/primary_doc.xml 0000950123-25-008390 028-13114 251219273 34 95212
2025-08-13 4 4 0000950170-25-108105 8053
2025-08-08 4 4 0000950170-25-105996 5123
2025-08-08 10-Q 10-Q 0001193125-25-176984 001-33551 251198399 34 27136793 1 1
2025-08-07 144 xsl144X01/primary_doc.xml 0001964306-25-000307 001-33551 251193769 33 5667
2025-08-06 4 4 0000950170-25-104065 6944
2025-08-05 144 xsl144X01/primary_doc.xml 0001964306-25-000306 001-33551 251186062 33 5071
2025-07-24 8-K 8-K 2.02,9.01 0001193125-25-163805 001-33551 251144470 34 3526932 1 1
2025-07-18 4 xslF345X05/ownership.xml 0001213900-25-065794 000-56726 251135316 34 16451
2025-07-15 4 4 0000950170-25-095936 14151
2025-07-10 4 4 0000950170-25-095018 15328
2025-06-27 3 3 0000950170-25-090900 000-56726 251086616 34 17049
2025-06-26 4 4 0000950170-25-090453 15204
2025-06-24 8-K 8-K 7.01,9.01 0001193125-25-145785 001-33551 251069812 34 145269 1 1
2025-06-23 144 xsl144X01/primary_doc.xml 0001964306-25-000268 001-33551 251065434 33 4636
2025-06-11 4 4 0000950170-25-084864 001-42030 251040421 34 27194
2025-05-28 4 4 0000950170-25-078387 001-40482 25995893 34 19341
2025-05-20 4 4 0000950170-25-075247 001-42030 25969371 34 36880
2025-05-15 13F-HR xslForm13F_X02/primary_doc.xml 0000950123-25-005761 028-13114 25955756 34 97160
2025-05-09 4 4 0000950170-25-068178 10759
2025-05-08 144 xsl144X01/primary_doc.xml 0001964306-25-000212 001-33551 25926977 33 4459
2025-05-06 4 4 0000950170-25-064641 8107
2025-05-02 4 4 0000950170-25-062954 000-56726 25910215 34 16028
2025-05-02 4 4 0000950170-25-062951 9908
2025-05-02 4 4 0000950170-25-062838 811-23996 25909114 34 15700
2025-05-02 10-Q 10-Q 0001193125-25-111595 001-33551 25908303 34 21196223 1 1
2025-04-18 4 4 0000950170-25-055931 001-39798 25851108 34 17967
2025-04-17 8-K 8-K 2.02,9.01 0001193125-25-083472 001-33551 25844278 34 3279892 1 1
2025-04-15 3 3 0000950170-25-054266 814-01853 25839931 34 15037
2025-04-03 4 4 0000950170-25-050588 14481
2025-04-03 4 4 0000950170-25-050582 18276
2025-04-03 4 4 0000950170-25-050578 14457
2025-04-03 4 4 0000950170-25-050575 14430
2025-04-03 4 4 0000950170-25-050568 15871
2025-04-03 4 4 0000950170-25-050524 14502
2025-03-25 8-K 8-K 7.01,9.01 0001193125-25-062559 001-33551 25768530 34 153885 1 1
2025-03-10 3 3 0000950170-25-036366 811-23996 25724236 34 15045
2025-03-05 4 4 0000950170-25-033816 14323
2025-02-28 S-8 S-8 0001193125-25-042529 333-285429 25690749 33 201819 1 1
2025-02-28 IRANNOTICE IRANNOTICE 0001193125-25-042497 001-33551 25690367 34 8602
2025-02-28 10-K 10-K 0001193125-25-042469 001-33551 25690042 34 37802291 1 1
2025-02-20 4 4 0000950170-25-024231 8051
2025-02-14 13F-HR xslForm13F_X02/primary_doc.xml 0000950123-25-002770 028-13114 25628270 34 92741
2025-02-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001422849-25-000020 005-83050 25621213 34 7539
2025-01-30 8-K 8-K 2.02,9.01 0001193125-25-016236 001-33551 25571135 34 3317580 1 1
2025-01-14 4 4 0000950170-25-005471 5244
2025-01-14 4 4 0000950170-25-005464 5246
2025-01-14 4 4 0000950170-25-005461 5203
2025-01-14 4 4 0000950170-25-005455 5231
2025-01-14 4 4 0000950170-25-005446 8983
2025-01-14 4 4 0000950170-25-005413 5175
2024-12-23 8-K 8-K 7.01,9.01 0001193125-24-284196 001-33551 241573794 34 153670 1 1
2024-12-23 4 4 0000950170-24-139577 5805
2024-12-20 4 4 0000950170-24-139127 10650
2024-12-16 4 4 0000950170-24-136679 001-42030 241552282 34 27203
2024-12-13 4 4 0000950170-24-136244 9392
2024-12-06 8-K 8-K 1.01,2.03,8.01,9.01 0001193125-24-272512 001-33551 241532849 34 1279875 1 1
2024-12-04 424B5 424B5 0001193125-24-270178 333-283540 241524759 33 862187 1 1
2024-12-03 8-K 8-K 8.01,9.01 0001193125-24-269114 001-33551 241520565 34 156591 1 1
2024-12-03 FWP FWP 0001193125-24-269112 24315
2024-12-02 8-K 8-K 8.01,9.01 0001193125-24-268451 001-33551 241517512 34 156069 1 1
2024-12-02 424B5 424B5 0001193125-24-268447 333-283540 241517496 33 671897
2024-12-02 S-3ASR S-3ASR 0001193125-24-268420 333-283540 241517435 33 1847928 1 1
2024-11-25 8-K 8-K 8.01,9.01 0001193125-24-264461 001-33551 241491110 34 35056824 1 1
2024-11-15 4 4 0000950170-24-127632 4574
2024-11-14 13F-HR xslForm13F_X02/primary_doc.xml 0000950123-24-011779 028-13114 241461764 34 94738
2024-11-13 8-K 8-K 5.02 0001193125-24-257241 001-33551 241454645 34 139405 1 1
2024-11-13 SC 13G SEC SCHEDULE 13G 0001422849-24-000064 005-83050 241453467 34 18315
2024-11-12 4 4 0000950170-24-125664 5926
2024-11-08 4 4 0000950170-24-124258 8868
2024-11-07 144 xsl144X01/primary_doc.xml 0001964306-24-000414 001-33551 241436172 33 5683
2024-11-06 4 4 0000950170-24-122381 8050
2024-11-01 IRANNOTICE IRANNOTICE 0001193125-24-249814 001-33551 241419043 34 10524
2024-11-01 10-Q 10-Q 0001193125-24-249809 001-33551 241419003 34 39793161 1 1
2024-10-28 4 4 0000950170-24-117876 001-38048 241402373 34 24660
2024-10-17 8-K 8-K 2.02,9.01 0001193125-24-238418 001-33551 241375905 34 3458271 1 1
2024-10-03 4 4 0000950170-24-112492 10528
2024-10-01 144 xsl144X01/primary_doc.xml 0001964306-24-000369 001-33551 241343586 33 6363
2024-09-24 8-K 8-K 7.01,9.01 0001193125-24-224792 001-33551 241320327 34 153056 1 1
2024-09-18 4 4 0000950170-24-107948 6601
2024-09-17 4 4 0000950170-24-107453 4895
2024-08-30 N-PX xslN-PX_X01/primary_doc.xml 0001021408-24-006455 028-13114 241268105 34 117558
2024-08-23 4 4 0000950170-24-100224 001-38366 241236825 34 28453
2024-08-14 13F-HR xslForm13F_X02/primary_doc.xml 0000950123-24-008646 028-13114 241205895 34 100820
2024-08-09 4 FORM 4 SUBMISSION 0001209191-24-005958 9071
2024-08-07 144 xsl144X01/primary_doc.xml 0001964306-24-000293 001-33551 241184133 33 4471
2024-08-07 4 FORM 4 SUBMISSION 0001209191-24-005956 8568
2024-08-05 4 FORM 4 SUBMISSION 0001209191-24-005954 5351
2024-08-02 IRANNOTICE IRANNOTICE 0001193125-24-192849 001-33551 241170901 34 8601
2024-08-02 10-Q 10-Q 0001193125-24-192846 001-33551 241170878 34 30155822 1 1
2024-07-31 4 FORM 4 SUBMISSION 0001209191-24-005952 4763
2024-07-31 144 xsl144X01/primary_doc.xml 0001964306-24-000285 001-33551 241163069 33 5675
2024-07-30 144 xsl144X01/primary_doc.xml 0001964306-24-000282 001-33551 241158077 33 5323
2024-07-30 144 xsl144X01/primary_doc.xml 0001964306-24-000279 001-33551 241157372 33 5057
2024-07-18 8-K 8-K 2.02,9.01 0001193125-24-180721 001-33551 241123675 34 3483638 1 1
2024-07-16 4 FORM 4 SUBMISSION 0001209191-24-005949 5105
2024-07-10 4 FORM 4 SUBMISSION 0001209191-24-005948 6270
2024-07-05 4 FORM 4 SUBMISSION 0001209191-24-005945 5504
2024-07-03 8-K 8-K 7.01 0001193125-24-175031 001-33551 241099996 34 144419 1 1
2024-07-03 144 xsl144X01/primary_doc.xml 0001964306-24-000266 001-33551 241099122 33 4582
2024-06-27 4 FORM 4 SUBMISSION 0001209191-24-005932 6167
2024-05-31 4 FORM 4 SUBMISSION 0001209191-24-005774 9595
2024-05-23 4 4 0000950170-24-064090 001-38366 24980041 34 28362
2024-05-21 SC 13D/A SC 13D/A 0001193125-24-143963 143642
2024-05-15 4 FORM 4 SUBMISSION 0001209191-24-005650 5117
2024-05-15 13F-HR xslForm13F_X02/primary_doc.xml 0000950123-24-005633 028-13114 24950318 34 108640
2024-05-10 3 3 0000950170-24-057875 001-41504 24935409 34 14700
2024-05-10 4 4 0000950170-24-057877 001-41862 24935399 34 27021
2024-05-08 4 FORM 4 SUBMISSION 0001209191-24-005569 8567
2024-05-03 IRANNOTICE IRANNOTICE 0001193125-24-130679 001-33551 24912953 34 9105
2024-05-03 10-Q 10-Q 0001193125-24-130670 001-33551 24912902 34 26486958 1 1
2024-04-29 4 4 0000950170-24-049949 001-38048 24891644 34 25482
2024-04-24 3 3 0000950170-24-047856 001-42030 24872542 34 22829
2024-04-18 8-K 8-K 2.02,9.01 0001193125-24-099867 001-33551 24852804 34 3241923 1 1
2024-04-03 4 4 0000950170-24-041318 001-40308 24820307 34 39511
2024-04-02 4 FORM 4 SUBMISSION 0001209191-24-005197 5607
2024-04-02 4 FORM 4 SUBMISSION 0001209191-24-005196 5681
2024-04-02 4 FORM 4 SUBMISSION 0001209191-24-005195 9392
2024-04-02 4 FORM 4 SUBMISSION 0001209191-24-005194 5669
2024-04-02 4 FORM 4 SUBMISSION 0001209191-24-005193 5634
2024-04-02 4 FORM 4 SUBMISSION 0001209191-24-005192 5678
2024-03-14 4 FORM 4 SUBMISSION 0000899243-24-000190 001-38366 24752069 34 96374
2024-03-12 4 4 0000950170-24-030068 001-40308 24743034 34 39501
2024-03-05 4 4 0000950170-24-026500 001-40054 24723205 34 41364
2024-02-23 S-8 S-8 0001193125-24-044644 333-277332 24672481 33 62151
2024-02-23 IRANNOTICE IRANNOTICE 0001193125-24-044492 001-33551 24671090 34 9744
2024-02-23 10-K 10-K 0001193125-24-044485 001-33551 24671070 34 36806875 1 1
2024-02-21 4 FORM 4 SUBMISSION 0001209191-24-003683 4773
2024-02-21 4 4 0000950170-24-017998 001-38366 24660400 34 28398
2024-02-14 4 FORM 4 SUBMISSION 0001209191-24-003358 8567
2024-02-14 13F-HR xslForm13F_X02/primary_doc.xml 0000950123-24-002536 028-13114 24637893 34 94369
2024-02-13 SC 13G/A SCHEDULE 13G/A 0001104659-24-020021 005-83050 24627073 34 13227
2024-02-09 4 FORM 4 SUBMISSION 0001209191-24-003032 11113
2024-02-09 4 FORM 4 SUBMISSION 0001209191-24-003028 7063
2024-02-09 144 xsl144X01/primary_doc.xml 0001964306-24-000037 001-33551 24615238 33 4579
2024-02-08 144 xsl144X01/primary_doc.xml 0001964306-24-000034 001-33551 24609415 33 5681
2024-01-29 SC 13G us09260d1072_012924.txt 0001086364-24-005138 005-83050 24573133 34 13985
2024-01-25 8-K 8-K 2.02,9.01 0001193125-24-014831 001-33551 24558541 34 2961971 1 1
2024-01-10 4 FORM 4 SUBMISSION 0001209191-24-001389 5474
2024-01-10 4 FORM 4 SUBMISSION 0001209191-24-001385 5462
2024-01-10 4 FORM 4 SUBMISSION 0001209191-24-001384 5431
2024-01-10 4 FORM 4 SUBMISSION 0001209191-24-001383 9189
2024-01-10 4 FORM 4 SUBMISSION 0001209191-24-001382 5478
2024-01-10 4 FORM 4 SUBMISSION 0001209191-24-001381 5404
2023-12-27 3 FORM 3 SUBMISSION 0001209191-23-059794 11603
2023-12-22 4 FORM 4 SUBMISSION 0001209191-23-059613 5351
2023-12-21 144 xsl144X01/primary_doc.xml 0001964306-23-000360 001-33551 231505435 33 5069
2023-12-20 8-K 8-K 1.01,2.03,9.01 0001193125-23-299933 001-33551 231501483 34 956368 1 1
2023-12-15 4 FORM 4 SUBMISSION 0000899243-23-020643 001-38366 231490779 34 28802
2023-12-05 4 FORM 4 SUBMISSION 0000899243-23-020549 001-40054 231467047 34 42123
2023-11-27 4 FORM 4 SUBMISSION 0000899243-23-020504 001-41862 231440612 34 27095
2023-11-16 4 FORM 4 SUBMISSION 0000899243-23-020408 001-41862 231415004 34 30877
2023-11-14 13F-HR xslForm13F_X02/primary_doc.xml 0000950123-23-010988 028-13114 231407715 34 92382
2023-11-14 4 FORM 4 SUBMISSION 0000899243-23-020347 001-40308 231407175 34 40161
2023-11-13 4 FORM 4 SUBMISSION 0000899243-23-020335 001-38048 231400496 34 25774
2023-11-13 4 FORM 4 SUBMISSION 0001209191-23-055055 6056
2023-11-09 3 FORM 3 SUBMISSION 0000899243-23-020316 001-41862 231394288 34 25849
2023-11-07 4 FORM 4 SUBMISSION 0001209191-23-054619 8513
2023-11-03 IRANNOTICE IRANNOTICE 0001193125-23-270365 001-33551 231376267 34 11616
2023-11-03 10-Q 10-Q 0001193125-23-270358 001-33551 231376245 34 33774941 1 1
2023-10-31 4 FORM 4 SUBMISSION 0001209191-23-053985 8993
2023-10-30 144 xsl144X01/primary_doc.xml 0001964306-23-000256 001-33551 231360769 33 4391
2023-10-19 8-K 8-K 2.02,9.01 0001193125-23-258911 001-33551 231333330 34 3483853 1 1
2023-10-02 4 FORM 4 SUBMISSION 0001209191-23-051239 7509
2023-10-02 144 xsl144X01/primary_doc.xml 0001964306-23-000242 001-33551 231299585 33 5091
2023-09-22 4 FORM 4 SUBMISSION 0001209191-23-050428 4697
2023-09-18 4 FORM 4 SUBMISSION 0001209191-23-049821 5050
2023-09-12 4 FORM 4 SUBMISSION 0000899243-23-018737 001-39270 231250463 34 12772
2023-09-11 4 FORM 4 SUBMISSION 0001209191-23-048980 6226
2023-09-08 144 xsl144X01/primary_doc.xml 0001964306-23-000211 001-33551 231246168 33 4401
2023-08-31 4 FORM 4 SUBMISSION 0001209191-23-047886 9519
2023-08-28 4 FORM 4 SUBMISSION 0001209191-23-047547 4946
2023-08-28 4 FORM 4 SUBMISSION 0000899243-23-018547 17984
2023-08-25 8-K 8-K 5.02 0001193125-23-221465 001-33551 231208177 34 138739 1 1
2023-08-22 4 FORM 4 SUBMISSION 0000899243-23-018353 001-39299 231194696 34 27710
2023-08-17 3 FORM 3 SUBMISSION 0000899243-23-018216 001-39270 231183267 34 16373
2023-08-16 4 FORM 4 SUBMISSION 0000899243-23-018185 001-39275 231179477 34 27696
2023-08-16 4 FORM 4 SUBMISSION 0000899243-23-018176 001-38366 231178562 34 27850
2023-08-14 4 FORM 4 SUBMISSION 0000899243-23-018137 001-40308 231172683 34 40151
2023-08-14 13F-HR xslForm13F_X02/primary_doc.xml 0000950123-23-008123 028-13114 231170332 34 90520
2023-08-09 4 FORM 4 SUBMISSION 0001209191-23-045225 10077
2023-08-08 SC 13G/A us09260d1072_080723.txt 0001306550-23-009694 005-83050 231149771 34 13047
2023-08-04 IRANNOTICE IRANNOTICE 0001193125-23-203845 001-33551 231143964 34 11370
2023-08-04 10-Q 10-Q 0001193125-23-203835 001-33551 231143940 34 30132256 1 1
2023-08-02 4 FORM 4 SUBMISSION 0000899243-23-017734 001-38048 231136780 34 25836
2023-07-27 4 FORM 4 SUBMISSION 0001209191-23-043577 5275
2023-07-26 144 xsl144X01/primary_doc.xml 0001964306-23-000126 001-33551 231112673 33 4387
2023-07-20 8-K 8-K 2.02,9.01 0001193125-23-190073 001-33551 231098049 34 3513233 1 1
2023-07-17 4 FORM 4 SUBMISSION 0001209191-23-042477 5029
2023-07-11 4 FORM 4 SUBMISSION 0001209191-23-042023 6175
2023-07-07 4 FORM 4 SUBMISSION 0000899243-23-017282 7502
2023-07-05 144 xsl144X01/primary_doc.xml 0001964306-23-000115 001-33551 231069427 33 5091
2023-06-28 4 FORM 4 SUBMISSION 0000899243-23-016658 11470
2023-06-27 4 FORM 4 SUBMISSION 0000899243-23-016554 6097
2023-06-22 4 FORM 4 SUBMISSION 0001209191-23-039138 5057
2023-06-16 4 FORM 4 SUBMISSION 0000899243-23-015774 001-39798 231021561 34 19413
2023-06-15 4 FORM 4 SUBMISSION 0000899243-23-015616 001-39709 231017798 34 23108
2023-06-12 4 FORM 4 SUBMISSION 0000899243-23-015401 001-39798 231009636 34 19413
2023-06-08 4 FORM 4 SUBMISSION 0000899243-23-014948 001-39798 231003301 34 21780
2023-06-01 4 FORM 4 SUBMISSION 0001209191-23-033405 9520
2023-05-25 4 FORM 4 SUBMISSION 0000899243-23-013897 001-38366 23961453 34 28106
2023-05-16 4 FORM 4 SUBMISSION 0001209191-23-029925 6812
2023-05-16 4 FORM 4 SUBMISSION 0001209191-23-029922 5041
2023-05-15 13F-HR xslForm13F_X02/primary_doc.xml 0000950123-23-005282 028-13114 23921944 34 96968
2023-05-10 4 FORM 4 SUBMISSION 0001209191-23-028506 8501
2023-05-05 IRANNOTICE IRANNOTICE 0001193125-23-137078 001-33551 23893730 34 8482
2023-05-05 10-Q 10-Q 0001193125-23-137073 001-33551 23893683 34 22299084 1 1
2023-05-05 4 FORM 4 SUBMISSION 0000899243-23-012325 001-38048 23891095 34 25833
2023-04-20 4 FORM 4 SUBMISSION 0000899243-23-011484 001-36505 23833820 34 18701
2023-04-20 8-K 8-K 2.02,9.01 0001193125-23-107336 001-33551 23831363 34 2927876 1 1
2023-04-18 4 FORM 4 SUBMISSION 0000899243-23-011395 001-36505 23827939 34 19277
2023-04-14 4 FORM 4 SUBMISSION 0000899243-23-011287 001-36505 23822237 34 19276
2023-04-12 4 FORM 4 SUBMISSION 0000899243-23-011202 001-36505 23816408 34 19275
2023-04-04 4 FORM 4 SUBMISSION 0001209191-23-023025 5593
2023-04-04 4 FORM 4 SUBMISSION 0001209191-23-023013 5561
2023-04-04 4 FORM 4 SUBMISSION 0001209191-23-023010 5607
2023-04-04 4 FORM 4 SUBMISSION 0001209191-23-023007 9319
2023-04-04 4 FORM 4 SUBMISSION 0001209191-23-023002 9864
2023-04-04 4 FORM 4 SUBMISSION 0000899243-23-010456 001-40308 23799754 34 39450
2023-04-04 4 FORM 4 SUBMISSION 0000899243-23-010437 001-33366 23799057 34 42656
2023-03-31 4 FORM 4 SUBMISSION 0000899243-23-010097 001-33366 23788249 34 42659
2023-03-29 4 FORM 4 SUBMISSION 0000899243-23-009999 001-33366 23776787 34 51552
2023-03-17 4 FORM 4 SUBMISSION 0000899243-23-008949 12597
2023-03-16 3 FORM 3 SUBMISSION 0000899243-23-008742 001-39709 23739413 34 20991
2023-03-14 4 FORM 4 SUBMISSION 0000899243-23-008352 001-38246 23730215 34 20829
2023-03-08 4 FORM 4 SUBMISSION 0000899243-23-007539 001-40054 23716457 34 51609
2023-03-06 4 FORM 4 SUBMISSION 0000899243-23-007245 001-39299 23710729 34 27495
2023-03-03 4 FORM 4 SUBMISSION 0001209191-23-015691 9636
2023-02-24 S-8 S-8 0001193125-23-048824 333-270007 23667947 33 62572
2023-02-24 IRANNOTICE IRANNOTICE 0001193125-23-048748 001-33551 23667077 34 9417
2023-02-24 10-K 10-K 0001193125-23-048733 001-33551 23666972 34 35245806 1 1
2023-02-15 4 FORM 4 SUBMISSION 0001209191-23-009862 9018
2023-02-14 13F-HR xslForm13F_X02/primary_doc.xml 0000950123-23-002685 028-13114 23630819 34 100596
2023-02-10 5 FORM 5 SUBMISSION 0000899243-23-004630 18278
2023-02-10 13F-HR/A xslForm13F_X02/primary_doc.xml 0000950123-23-001525 028-13114 23611611 34 118063
2023-02-09 SC 13G/A SCHEDULE 13G/A 0001104659-23-015065 005-83050 23602035 34 13194
2023-02-07 4 FORM 4 SUBMISSION 0001209191-23-007697 15476
2023-02-06 SC 13G/A SEC SCHEDULE 13G 0000846087-23-000084 005-83050 23590075 34 33453
2023-02-03 4 FORM 4 SUBMISSION 0001209191-23-007171 8962
2023-02-02 4 FORM 4 SUBMISSION 0000899243-23-003493 001-38048 23581551 34 25819
2023-02-01 SC 13G/A us09260d1072_020123.txt 0001306550-23-006374 005-83050 23577452 34 13764
2023-01-30 4 FORM 4 SUBMISSION 0000899243-23-002983 001-36505 23569309 34 19242
2023-01-26 8-K 8-K 2.02,9.01 0001193125-23-015663 001-33551 23553875 34 3273446 1 1
2023-01-24 3 FORM 3 SUBMISSION 0000899243-23-002535 001-41603 23549574 34 23092
2023-01-17 4 FORM 4 SUBMISSION 0000899243-23-001875 001-40308 23532340 34 32912
2023-01-11 4 FORM 4 SUBMISSION 0001209191-23-003002 5371
2023-01-11 4 FORM 4 SUBMISSION 0001209191-23-002999 11702
2023-01-11 4 FORM 4 SUBMISSION 0001209191-23-002994 5326

Latest XBRL company facts

One latest value per concept from companyfacts (432 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 751.12M 2026-10-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
dei EntityPublicFloat Entity Public Float USD 108.90B 2025-06-30 2025 FY 10-K 2026-02-27 0001193125-26-082531
us-gaap AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent Accounts Payable and Accrued Liabilities USD 3.43B 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap AccountsReceivableNet Accounts Receivable, after Allowance for Credit Loss USD 451.49M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 494.80M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -18.79M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap AcquiredFiniteLivedIntangibleAssetAmount Acquired Finite-lived Intangible Asset, Amount (Deprecated 2013-01-31) USD 23.40M 2011-05-16 2011 Q3 10-Q 2011-11-09 0001193125-11-304545
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 9.24B 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesOther Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities, Other (Deprecated 2011-01-31) USD 14.81M 2011-01-01 2011-03-31 2011 Q1 10-Q 2011-05-06 0001193125-11-130720
us-gaap AdjustmentsToAdditionalPaidInCapitalOther Adjustments to Additional Paid in Capital, Other USD 6.25M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap AdjustmentsToAdditionalPaidInCapitalReallocationOfMinorityInterest Adjustments to Additional Paid in Capital, Reallocation of Noncontrolling Interest (Deprecated 2013-01-31) USD -60.20M 2010-01-01 2010-06-30 2010 Q2 10-Q 2010-08-06 0001193125-10-181364
us-gaap AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet Adjustment to Additional Paid in Capital, Income Tax Effect from Share-based Compensation, Net USD 70.32M 2015-01-01 2015-12-31 2017 FY 10-K 2018-03-01 0001193125-18-067079
us-gaap AdvancesToAffiliate Advances to Affiliate USD 21.14M 2015-09-30 2015 Q3 10-Q 2015-11-05 0001193125-15-368290
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 176.81M 2020-01-01 2020-06-30 2020 Q2 10-Q 2020-08-07 0001193125-20-213629
us-gaap AlternativeInvestment Alternative Investment USD 179.10M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap AlternativeInvestmentsFairValueDisclosure Alternative Investment, Fair Value Disclosure (Deprecated 2018-01-31) USD 462.44M 2018-03-31 2018 Q1 10-Q 2018-05-08 0001193125-18-155958
us-gaap AmortizationOfIntangibleAssets Amortization of Intangible Assets USD 27.11M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap Assets Assets USD 49.64B 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap AssetsFairValueDisclosure Assets, Fair Value Disclosure USD 6.95B 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap BusinessAcquisitionCostOfAcquiredEntityCashPaid Business Acquisition, Cost of Acquired Entity, Cash Paid (Deprecated 2013-01-31) EUR 181.40M 2012-01-05 2012 FY 10-K 2013-03-01 0001193125-13-087702
us-gaap BusinessAcquisitionCostOfAcquiredEntityEquityInterestsIssuedAndIssuable Business Acquisition, Cost of Acquired Entity, Equity Interests Issued and Issuable (Deprecated 2013-01-31) USD 280.00M 2008-03-31 2011 FY 10-K 2012-02-28 0001193125-12-085636
us-gaap BusinessAcquisitionCostOfAcquiredEntityOtherNoncashConsideration Business Acquisition, Cost of Acquired Entity, Other Noncash Consideration (Deprecated 2013-01-31) USD 310.00M 2008-03-31 2011 FY 10-K 2012-02-28 0001193125-12-085636
us-gaap BusinessAcquisitionCostOfAcquiredEntityPurchasePrice Business Acquisition, Cost of Acquired Entity, Purchase Price (Deprecated 2013-01-31) USD 232.04M 2012-01-05 2012 FY 10-K 2013-03-01 0001193125-13-087702
us-gaap BusinessAcquisitionProFormaEarningsPerShareBasic Business Acquisition, Pro Forma Earnings Per Share, Basic USD/shares 0.31 2011-01-01 2011-06-30 2012 Q2 10-Q 2012-08-07 0001193125-12-340947
us-gaap BusinessAcquisitionProFormaEarningsPerShareDiluted Business Acquisition, Pro Forma Earnings Per Share, Diluted USD/shares 0.31 2011-01-01 2011-06-30 2012 Q2 10-Q 2012-08-07 0001193125-12-340947
us-gaap BusinessAcquisitionPurchasePriceAllocationAmortizableIntangibleAssets Business Acquisition, Purchase Price Allocation, Amortizable Intangible Assets (Deprecated 2013-01-31) USD 142.22M 2012-01-05 2012 FY 10-K 2013-03-01 0001193125-13-087702
us-gaap BusinessAcquisitionPurchasePriceAllocationAssetsAcquired Business Acquisition, Purchase Price Allocation, Assets Acquired (Deprecated 2013-01-31) USD 253.58M 2012-01-05 2012 FY 10-K 2013-03-01 0001193125-13-087702
us-gaap BusinessAcquisitionPurchasePriceAllocationAssetsAcquiredLiabilitiesAssumedNet Business Acquisition, Purchase Price Allocation, Assets Acquired (Liabilities Assumed), Net (Deprecated 2013-01-31) USD 232.04M 2012-01-05 2012 FY 10-K 2013-03-01 0001193125-13-087702
us-gaap BusinessAcquisitionPurchasePriceAllocationCurrentAssetsCashAndCashEquivalents Business Acquisition, Purchase Price Allocation, Current Assets, Cash and Cash Equivalents (Deprecated 2013-01-31) USD 75.07M 2012-01-05 2012 FY 10-K 2013-03-01 0001193125-13-087702
us-gaap BusinessAcquisitionPurchasePriceAllocationCurrentAssetsPrepaidExpenseAndOtherAssets Business Acquisition, Purchase Price Allocation, Current Assets, Prepaid Expense and Other Assets (Deprecated 2013-01-31) USD 17.65M 2012-01-05 2012 FY 10-K 2013-03-01 0001193125-13-087702
us-gaap BusinessAcquisitionPurchasePriceAllocationCurrentAssetsReceivables Business Acquisition, Purchase Price Allocation, Current Assets, Receivables (Deprecated 2013-01-31) USD 9.33M 2012-01-05 2012 FY 10-K 2013-03-01 0001193125-13-087702
us-gaap BusinessAcquisitionPurchasePriceAllocationCurrentLiabilities Business Acquisition, Purchase Price Allocation, Current Liabilities (Deprecated 2013-01-31) USD 21.53M 2012-01-05 2012 FY 10-K 2013-03-01 0001193125-13-087702
us-gaap BusinessAcquisitionsProFormaNetIncomeLoss Business Acquisition, Pro Forma Net Income (Loss) USD -270.80M 2011-01-01 2011-12-31 2012 FY 10-K 2013-03-01 0001193125-13-087702
us-gaap BusinessAcquisitionsProFormaRevenue Business Acquisition, Pro Forma Revenue USD 3.25B 2011-01-01 2011-12-31 2012 FY 10-K 2013-03-01 0001193125-13-087702
us-gaap BusinessCombinationAcquisitionRelatedCosts Business Combination, Acquisition Related Costs USD 580.90M 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-01 0001193125-19-061011
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 3.04B 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap CashAndCashEquivalentsFairValueDisclosure Cash and Cash Equivalents, Fair Value Disclosure USD 988.68M 2017-03-31 2017 Q1 10-Q 2017-05-09 0001193125-17-164159
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD 155.24M 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-01 0001193125-18-067079
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 3.27B 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 411.56M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap CashDivestedFromDeconsolidation Cash Divested from Deconsolidation USD 666,000 2011-01-01 2011-09-30 2011 Q3 10-Q 2011-11-09 0001193125-11-304545
us-gaap ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge (Deprecated 2013-01-31) USD -794,000 2012-01-01 2012-03-31 2013 Q1 10-Q 2013-05-08 0001193125-13-207420
us-gaap ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1 Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge USD -22.60M 2012-01-01 2012-12-31 2014 FY 10-K 2015-02-27 0001193125-15-069653
us-gaap CollateralSecuritiesRepledgedDeliveredOrUsed Collateral Securities Repledged, Delivered, or Used USD 117.80M 2016-12-31 2017 FY 10-K 2018-03-01 0001193125-18-067079
us-gaap CommonStockDividendsPerShareDeclared Common Stock, Dividends, Per Share, Declared USD/shares 3.94 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 90.00B 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 760.15M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 760.15M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap CommonStockValue Common Stock, Value, Issued USD 7,000 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap CommonUnitIssuanceValue Common Unit, Issuance Value USD 75.77M 2018-12-31 2020 FY 10-K 2021-02-26 0001193125-21-060361
us-gaap CommonUnitIssued Common Unit, Issued shares 663.21M 2018-12-31 2019 FY 10-K 2020-02-28 0001193125-20-056733
us-gaap CommonUnitOutstanding Common Unit, Outstanding shares 663.21M 2018-12-31 2019 Q3 10-Q 2019-11-08 0001193125-19-288342
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD 2.53B 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest USD 2.30B 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest USD 4.83B 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap ConversionOfStockAmountIssued Conversion of Stock, Amount Issued (Deprecated 2011-01-31) USD 137.96M 2011-03-31 2011 Q1 10-Q 2011-05-06 0001193125-11-130720
us-gaap ConversionOfStockAmountIssued1 Conversion of Stock, Amount Issued USD 55.84M 2023-01-01 2023-12-31 8-K 2024-11-25 0001193125-24-264461
us-gaap CostsAndExpenses Costs and Expenses USD 6.26B 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD 354.54M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-082531
us-gaap CurrentForeignTaxExpenseBenefit Current Foreign Tax Expense (Benefit) USD 142.10M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-082531
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD 683.59M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-082531
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD 186.95M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-082531
us-gaap DebtInstrumentCarryingAmount Long-term Debt, Gross USD 13.40B 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap DebtInstrumentCollateralAmount Debt Instrument, Collateral Amount USD 7.20B 2019-12-31 2020 FY 10-K 2021-02-26 0001193125-21-060361
us-gaap DebtInstrumentFairValue Debt Instrument, Fair Value Disclosure USD 11.72B 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap DebtInstrumentInterestRateStatedPercentage Debt Instrument, Interest Rate, Stated Percentage pure 0.015 2019-06-30 2019 Q2 10-Q 2019-08-08 0001193125-19-216805
us-gaap DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction USD 2.00M 2010-01-01 2010-12-31 2011 FY 10-K 2012-02-28 0001193125-12-085636
us-gaap DebtorInPossessionFinancingBorrowingsOutstanding Debtor-in-Possession Financing, Borrowings Outstanding USD 0 2011-09-30 2011 Q3 10-Q 2011-11-09 0001193125-11-304545
us-gaap DebtWeightedAverageInterestRate Debt, Weighted Average Interest Rate pure 0.039 2018-12-31 2018 FY 10-K 2019-03-01 0001193125-19-061011
us-gaap DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount Deconsolidation, Revaluation of Retained Investment, Gain (Loss), Amount USD -389.34M 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-02 0001193125-25-111595
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD 362.99M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-082531
us-gaap DeferredForeignIncomeTaxExpenseBenefit Deferred Foreign Income Tax Expense (Benefit) USD -3.82M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-082531
us-gaap DeferredIncomeTaxAssetsNet Deferred Income Tax Assets, Net USD 1.83B 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD 441.43M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-082531
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 16.48M 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-082531
us-gaap DeferredStateAndLocalIncomeTaxExpenseBenefit Deferred State and Local Income Tax Expense (Benefit) USD 82.26M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-082531
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 2.09B 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-082531
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 1.39B 2020-03-31 2020 Q1 10-Q 2020-05-08 0001193125-20-137560
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 2.33B 2023-12-31 8-K 2024-11-25 0001193125-24-264461
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 8.88M 2017-12-31 2018 FY 10-K 2019-03-01 0001193125-19-061011
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration USD 46.50M 2012-12-31 2012 FY 10-K 2013-03-01 0001193125-13-087702
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration USD 54.60M 2013-12-31 2014 FY 10-K 2015-02-27 0001193125-15-069653
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 211.60M 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-082531
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 69.48M 2018-12-31 2019 FY 10-K 2020-02-28 0001193125-20-056733
us-gaap DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross Deferred Tax Assets, Unrealized Losses on Available-for-Sale Securities, Gross USD 1.88B 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-082531
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 36.10M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap DeferredTaxLiabilities Deferred Tax Liabilities, Net USD 10,000 2014-12-31 2014 FY 10-K 2015-02-27 0001193125-15-069653
us-gaap DeferredTaxLiabilitiesOther Deferred Tax Liabilities, Other USD 1.68M 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-082531
us-gaap DefinedContributionPlanEmployerMatchingContributionPercentOfMatch Defined Contribution Plan, Employer Matching Contribution, Percent of Match pure 0.5 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-01 0001193125-18-067079
us-gaap DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount Defined Contribution Plan, Maximum Annual Contributions Per Employee, Amount USD 1,600 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-01 0001193125-18-067079
us-gaap Depreciation Depreciation USD 98.00M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-082531
us-gaap DerivativeAssetNotionalAmount Derivative Asset, Notional Amount USD 2.23B 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap DerivativeAssets Derivative Asset USD 4.84M 2017-03-31 2017 Q1 10-Q 2017-05-09 0001193125-17-164159
us-gaap DerivativeAssetSecuritiesPurchasedUnderAgreementsToResellSecuritiesBorrowed Derivative Asset, Securities Purchased under Agreements to Resell, Securities Borrowed USD 124.22M 2016-12-31 2017 FY 10-K 2018-03-01 0001193125-18-067079
us-gaap DerivativeAssetSecuritiesPurchasedUnderAgreementsToResellSecuritiesBorrowedAmountOffsetAgainstCollateral Derivative Asset, Securities Purchased under Agreements to Resell, Securities Borrowed, Amount Offset Against Collateral USD 2.48M 2016-12-31 2017 FY 10-K 2018-03-01 0001193125-18-067079
us-gaap DerivativeAssetSecuritiesPurchasedUnderAgreementsToResellSecuritiesBorrowedCollateralObligationToReturnCash Derivative Asset, Securities Purchased under Agreements to Resell, Securities Borrowed, Collateral, Obligation to Return Cash USD 2.89M 2016-12-31 2017 FY 10-K 2018-03-01 0001193125-18-067079
us-gaap DerivativeAssetSecuritiesPurchasedUnderAgreementsToResellSecuritiesBorrowedCollateralObligationToReturnSecurities Derivative Asset, Securities Purchased under Agreements to Resell, Securities Borrowed, Collateral, Obligation to Return Securities USD 118.84M 2016-12-31 2017 FY 10-K 2018-03-01 0001193125-18-067079
us-gaap DerivativeCollateralObligationToReturnSecurities Derivative, Collateral, Obligation to Return Securities USD 100.38M 2025-03-31 2025 Q1 10-Q 2025-05-02 0001193125-25-111595
us-gaap DerivativeFairValueOfDerivativeAsset Derivative Asset, Fair Value, Gross Asset USD 177.66M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap DerivativeFairValueOfDerivativeLiability Derivative Liability, Fair Value, Gross Liability USD 1.30B 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap DerivativeGainLossOnDerivativeNet Derivative, Gain (Loss) on Derivative, Net USD 12.24M 2016-01-01 2016-12-31 2016 FY 10-K 2017-02-24 0001193125-17-056300
us-gaap DerivativeLiabilityNotionalAmount Derivative Liability, Notional Amount USD 4.24B 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoaned Derivative Liability, Securities Sold under Agreements to Repurchase, Securities Loaned USD 445.28M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedAmountOffsetAgainstCollateral Derivative Liability, Securities Sold under Agreements to Repurchase, Securities Loaned, Amount Offset Against Collateral USD 4.85M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedCollateralRightToReclaimCash Derivative Liability, Securities Sold under Agreements to Repurchase, Securities Loaned, Collateral, Right to Reclaim Cash USD 22,000 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedCollateralRightToReclaimSecurities Derivative Liability, Securities Sold under Agreements to Repurchase, Securities Loaned, Collateral, Right to Reclaim Securities USD 440.40M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap DistributionMadeToMemberOrLimitedPartnerCashDistributionsDeclared Distribution Made to Member or Limited Partner, Cash Distributions Declared (Deprecated 2013-01-31) USD 356.96M 2009-01-01 2009-12-31 2011 FY 10-K 2012-02-28 0001193125-12-085636
us-gaap DividendsCash Dividends, Cash USD 0.1 2011-10-01 2011-12-31 2011 FY 10-K 2012-02-28 0001193125-12-085636
us-gaap DueFromAffiliates Due from Affiliates USD 4.10B 2023-03-31 2023 Q1 10-Q 2023-05-05 0001193125-23-137073
us-gaap DueFromRelatedParties Due from Related Parties USD 646.25M 2017-09-30 2017 Q3 10-Q 2017-11-07 0001193125-17-335723
us-gaap DueToRelatedPartiesCurrentAndNoncurrent Due to Related Parties USD 1.97B 2023-03-31 2023 Q1 10-Q 2023-05-05 0001193125-23-137073
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares 3.2 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares 0.44 2014-01-01 2014-03-31 2014 Q1 10-Q 2014-05-08 0001193125-14-190051
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares 3.19 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap EarningsPerShareDilutedUndistributed Earnings Per Share, Diluted, Undistributed USD/shares -3.71 2009-01-01 2009-12-31 2011 FY 10-K 2012-02-28 0001193125-12-085636
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0.157 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-082531
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2018-01-01 2018-12-31 2020 FY 10-K 2021-02-26 0001193125-21-060361
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure 0 2023-01-01 2023-12-31 8-K 2024-11-25 0001193125-24-264461
us-gaap EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent pure 0.083 2017-01-01 2017-12-31 2020 FY 10-K 2021-02-26 0001193125-21-060361
us-gaap EffectiveIncomeTaxRateReconciliationDeductions Effective Income Tax Rate Reconciliation, Deduction, Percent pure 0.015 2015-01-01 2015-12-31 2015 FY 10-K 2016-02-26 0001193125-16-481948
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure 0.011 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-082531
us-gaap EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense Effective Income Tax Rate Reconciliation, Noncontrolling Interest Income (Loss), Percent pure 0.088 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-082531
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent pure 0.002 2015-01-01 2015-12-31 2015 FY 10-K 2016-02-26 0001193125-16-481948
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure 0.004 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-082531
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure -0.001 2017-01-01 2017-12-31 2019 FY 10-K 2020-02-28 0001193125-20-056733
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure -0.009 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-082531
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0.029 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-082531
us-gaap EffectOfExchangeRateOnCashAndCashEquivalents Effect of Exchange Rate on Cash and Cash Equivalents USD 20.85M 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-01 0001193125-18-067079
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD -6.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap EmployeeRelatedLiabilitiesCurrentAndNoncurrent Employee-related Liabilities USD 7.10B 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 2.70B 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized, Period for Recognition (Deprecated 2012-01-31) Y 3.1 2012-01-01 2012-03-31 2012 Q1 10-Q 2012-05-07 0001193125-12-215062
us-gaap EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense Share-based Payment Arrangement, Expense, Tax Benefit USD 180.40M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap EquityMethodInvestmentOwnershipPercentage Equity Method Investment, Ownership Percentage pure 0.4 2015-12-31 2015 FY 10-K 2016-02-26 0001193125-16-481948
us-gaap EquityMethodInvestments Equity Method Investments USD 562.60M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap EquityMethodInvestmentSummarizedFinancialInformationAssets Equity Method Investment, Summarized Financial Information, Assets (Deprecated 2020-01-31) USD 284.93B 2019-12-31 2019 FY 10-K 2020-02-28 0001193125-20-056733
us-gaap EquityMethodInvestmentSummarizedFinancialInformationEquity Equity Method Investment Summarized Financial Information, Equity (Deprecated 2020-01-31) USD 229.05B 2019-12-31 2019 FY 10-K 2020-02-28 0001193125-20-056733
us-gaap EquityMethodInvestmentSummarizedFinancialInformationLiabilities Equity Method Investment, Summarized Financial Information, Liabilities (Deprecated 2020-01-31) USD 55.88B 2019-12-31 2019 FY 10-K 2020-02-28 0001193125-20-056733
us-gaap EquityMethodInvestmentSummarizedFinancialInformationLiabilitiesAndEquity Equity Method Investment, Summarized Financial Information, Liabilities and Equity (Deprecated 2020-01-31) USD 284.93B 2019-12-31 2019 FY 10-K 2020-02-28 0001193125-20-056733
us-gaap EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss Equity Method Investment, Summarized Financial Information, Net Income (Loss) (Deprecated 2020-01-31) USD 20.28B 2019-01-01 2019-12-31 2019 FY 10-K 2020-02-28 0001193125-20-056733
us-gaap EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Annual Amount USD 9.20M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-082531
us-gaap EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Cumulative Amount USD 19.30M 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-082531
us-gaap ExcessTaxBenefitFromShareBasedCompensationFinancingActivities Excess Tax Benefit from Share-based Compensation, Financing Activities USD 70.32M 2015-01-01 2015-12-31 2017 FY 10-K 2018-03-01 0001193125-18-067079
us-gaap ExcessTaxBenefitFromShareBasedCompensationOperatingActivities Excess Tax Benefit from Share-based Compensation, Operating Activities USD 70.32M 2015-01-01 2015-12-31 2017 FY 10-K 2018-03-01 0001193125-18-067079
us-gaap FairValueConcentrationOfRiskInvestments Fair Value, Concentration of Risk, Investments USD 21.70M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareUnfundedCommittments Fair Value, Investments, Entities that Calculate Net Asset Value Per Share, Unfunded Commitments USD 394,000 2020-03-31 2020 Q1 10-Q 2020-05-08 0001193125-20-137560
us-gaap FairValueLevel1ToLevel2TransfersAmount Fair Value, Level 1 to level 2 Transfers, Amount (Deprecated 2012-01-31) USD 29.52M 2012-01-01 2012-03-31 2012 Q1 10-Q 2012-05-07 0001193125-12-215062
us-gaap FairValueLevel2ToLevel1TransfersAmount Fair Value, Level 2 to level 1 Transfers, Amount (Deprecated 2012-01-31) USD 271,000 2012-01-01 2012-03-31 2012 Q1 10-Q 2012-05-07 0001193125-12-215062
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings (Deprecated 2012-01-31) USD 92.62M 2012-01-01 2012-03-31 2012 Q1 10-Q 2012-05-07 0001193125-12-215062
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Purchases USD 191.57M 2012-01-01 2012-03-31 2012 Q1 10-Q 2012-05-07 0001193125-12-215062
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Purchases, (Sales), Issuances, (Settlements) USD -84.42M 2010-01-01 2010-12-31 2011 FY 10-K 2012-02-28 0001193125-12-085636
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Sales USD -67.46M 2012-01-01 2012-03-31 2012 Q1 10-Q 2012-05-07 0001193125-12-215062
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Settlements USD -46,000 2012-01-01 2012-03-31 2012 Q1 10-Q 2012-05-07 0001193125-12-215062
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value USD 2.52B 2012-03-31 2012 Q1 10-Q 2012-05-07 0001193125-12-215062
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value USD 0 2020-03-31 2020 Q1 10-Q 2020-05-08 0001193125-20-137560
us-gaap FairValueOfSecuritiesReceivedAsCollateralThatHaveBeenResoldOrRepledged Fair Value of Securities Received as Collateral that Have Been Resold or Repledged USD 311.20M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap FinancialInstrumentsSoldNotYetPurchasedAtFairValue Financial Instruments Sold, Not yet Purchased, at Fair Value USD 3.82M 2023-06-30 2023 Q2 10-Q 2023-08-04 0001193125-23-203835
us-gaap FinancialLiabilitiesFairValueDisclosure Financial Liabilities Fair Value Disclosure USD 1.04M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap FiniteLivedIntangibleAssetsAccumulatedAmortization Finite-Lived Intangible Assets, Accumulated Amortization USD 1.65B 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap FiniteLivedIntangibleAssetsAcquired Finite-lived Intangible Assets Acquired (Deprecated 2013-01-31) USD 142.22M 2012-01-01 2012-12-31 2012 FY 10-K 2013-03-01 0001193125-13-087702
us-gaap FinitelivedIntangibleAssetsAcquired1 Finite-lived Intangible Assets Acquired USD 2.14M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-082531
us-gaap FiniteLivedIntangibleAssetsAmortizationExpense Finite-Lived Intangible Assets, Amortization Expense (Deprecated 2012-01-31) USD 48.10M 2012-01-01 2012-03-31 2012 Q1 10-Q 2012-05-07 0001193125-12-215062
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths Finite-Lived Intangible Asset, Expected Amortization, Year One USD 35.10M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year USD 36.10M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFive Finite-Lived Intangible Asset, Expected Amortization, Year Five USD 14.00M 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-082531
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFour Finite-Lived Intangible Asset, Expected Amortization, Year Four USD 14.00M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearThree Finite-Lived Intangible Asset, Expected Amortization, Year Three USD 17.00M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo Finite-Lived Intangible Asset, Expected Amortization, Year Two USD 18.20M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap FiniteLivedIntangibleAssetsGross Finite-Lived Intangible Assets, Gross USD 1.75B 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap FiniteLivedIntangibleAssetsNet Finite-Lived Intangible Assets, Net USD 104.25M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap FiniteLivedIntangibleAssetsUsefulLifeMaximum Finite-Lived Intangible Assets, Useful Life, Maximum (Deprecated 2012-01-31) years 20 2011-01-01 2011-12-31 2011 FY 10-K 2012-02-28 0001193125-12-085636
us-gaap FiniteLivedIntangibleAssetsUsefulLifeMinimum Finite-Lived Intangible Assets, Useful Life, Minimum (Deprecated 2012-01-31) years 4 2011-01-01 2011-12-31 2011 FY 10-K 2012-02-28 0001193125-12-085636
us-gaap FiniteLivedIntangibleAssetsWeightedAverageUsefulLife Finite-Lived Intangible Assets, Weighted-Average Useful Life (Deprecated 2012-01-31) Y 8.85 2012-01-01 2012-03-31 2012 Q1 10-Q 2012-05-07 0001193125-12-215062
us-gaap ForeignCurrencyTransactionGainLossBeforeTax Foreign Currency Transaction Gain (Loss), before Tax USD 73.80M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap FutureAmortizationExpenseYearFive Future Amortization Expense, Year Five (Deprecated 2012-01-31) USD 72.80M 2012-01-01 2012-03-31 2012 Q1 10-Q 2012-05-07 0001193125-12-215062
us-gaap FutureAmortizationExpenseYearFour Future Amortization Expense, Year Four (Deprecated 2012-01-31) USD 77.10M 2012-01-01 2012-03-31 2012 Q1 10-Q 2012-05-07 0001193125-12-215062
us-gaap FutureAmortizationExpenseYearOne Future Amortization Expense, Year One (Deprecated 2012-01-31) USD 139.30M 2012-01-01 2012-03-31 2012 Q1 10-Q 2012-05-07 0001193125-12-215062
us-gaap FutureAmortizationExpenseYearThree Future Amortization Expense, Year Three (Deprecated 2012-01-31) USD 83.30M 2012-01-01 2012-03-31 2012 Q1 10-Q 2012-05-07 0001193125-12-215062
us-gaap FutureAmortizationExpenseYearTwo Future Amortization Expense, Year Two (Deprecated 2012-01-31) USD 88.20M 2012-01-01 2012-03-31 2012 Q1 10-Q 2012-05-07 0001193125-12-215062
us-gaap GainLossOnComponentsExcludedFromAssessmentOfInterestRateFairValueHedgeEffectiveness Gain (Loss) on Components Excluded from Assessment of Interest Rate Fair Value Hedge Effectiveness USD -938,000 2012-01-01 2012-12-31 2014 FY 10-K 2015-02-27 0001193125-15-069653
us-gaap GainLossOnFairValueHedgesRecognizedInEarnings Gain (Loss) on Fair Value Hedges Recognized in Earnings USD 64.20M 2016-01-01 2016-12-31 2016 FY 10-K 2017-02-24 0001193125-17-056300
us-gaap GainLossOnInterestRateCashFlowHedgeIneffectiveness Gain (Loss) on Interest Rate Cash Flow Hedge Ineffectiveness USD 22.94M 2012-01-01 2012-12-31 2014 FY 10-K 2015-02-27 0001193125-15-069653
us-gaap GainLossOnInterestRateFairValueHedgeIneffectiveness Gain (Loss) on Interest Rate Fair Value Hedge Ineffectiveness USD 548,000 2012-01-01 2012-12-31 2014 FY 10-K 2015-02-27 0001193125-15-069653
us-gaap GainLossOnInvestments Gain (Loss) on Investments USD 4.19B 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap GainLossOnSaleOfDerivatives Gain (Loss) on Sale of Derivatives USD -8.92M 2017-01-01 2017-06-30 2017 Q2 10-Q 2017-08-08 0001193125-17-251308
us-gaap GainLossOnSaleOfOtherInvestments Gain (Loss) on Sale of Other Investments USD 5.49M 2017-01-01 2017-03-31 2017 Q1 10-Q 2017-05-09 0001193125-17-164159
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 1.20B 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap Goodwill Goodwill USD 1.89B 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap GoodwillTransfers Goodwill, Transfers USD -11.85M 2015-01-01 2015-12-31 2017 FY 10-K 2018-03-01 0001193125-18-067079
us-gaap IncentiveFeeExpense Incentive Fee Expense USD 153.36M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap IncomeLossAttributableToNoncontrollingInterest Income (Loss) Attributable to Noncontrolling Interest, before Tax USD 399.78M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD 5.79B 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest USD 3.15B 2013-01-01 2013-12-31 2013 FY 10-K 2014-02-28 0001193125-14-077145
us-gaap IncomeLossFromEquityMethodInvestments Income (Loss) from Equity Method Investments USD 314.40M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap IncomeTaxesPaid Income Taxes Paid USD 191.36M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 562.56M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-082531
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 908.10M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap IncomeTaxPaidFederalAfterRefundReceived IncomeTaxPaidFederalAfterRefundReceived USD 409.54M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-082531
us-gaap IncomeTaxPaidForeignAfterRefundReceived IncomeTaxPaidForeignAfterRefundReceived USD 81.52M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-082531
us-gaap IncomeTaxPaidStateAndLocalAfterRefundReceived IncomeTaxPaidStateAndLocalAfterRefundReceived USD 68.50M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-082531
us-gaap IncomeTaxReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount USD 76.21M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-082531
us-gaap IncomeTaxReconciliationMinorityInterestIncomeExpense Effective Income Tax Rate Reconciliation, Noncontrolling Interest Income (Loss), Amount USD 632.66M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-082531
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 30.47M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-082531
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD -61.88M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-082531
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 206.84M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-082531
us-gaap IncreaseDecreaseDueFromAffiliates Increase (Decrease) Due from Affiliates USD -254.59M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD 456.24M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD 130.56M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap IncreaseDecreaseInAccruedSalaries Increase (Decrease) in Accrued Salaries USD -921.51M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap IncreaseDecreaseInDueToAffiliates Increase (Decrease) in Due to Affiliates USD 48.79M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap IncreaseDecreaseInEmployeeRelatedLiabilities Increase (Decrease) in Employee Related Liabilities USD 2.17M 2010-01-01 2010-06-30 2010 Q2 10-Q 2010-08-06 0001193125-10-181364
us-gaap IncreaseDecreaseInFinancialInstrumentsSoldNotYetPurchased Increase (Decrease) in Financial Instruments Sold, Not yet Purchased USD -2,000 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-04 0001193125-23-203835
us-gaap IncreaseDecreaseInFinancialInstrumentsUsedInOperatingActivities Increase (Decrease) in Financial Instruments Used in Operating Activities USD 2.01B 2015-01-01 2015-06-30 2015 Q2 10-Q 2015-08-06 0001193125-15-280954
us-gaap IncreaseDecreaseInIncomeTaxes Increase (Decrease) in Income Taxes USD 158.20M 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-24 0001193125-23-048733
us-gaap IncreaseDecreaseInOtherFinancialInstrumentsUsedInOperatingActivities Increase (Decrease) in Other Financial Instruments Used in Operating Activities USD 61.38M 2015-01-01 2015-06-30 2015 Q2 10-Q 2015-08-06 0001193125-15-280954
us-gaap IncreaseDecreaseInOtherOperatingAssets Increase (Decrease) in Other Operating Assets USD -193.70M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap IncreaseDecreaseInPayablesUnderRepurchaseAgreements Increase (Decrease) in Payables under Repurchase Agreements USD -71.68M 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-04 0001193125-23-203835
us-gaap IncreaseDecreaseInReceivablesUnderRepurchaseAgreements Increase (Decrease) in Receivables under Repurchase Agreements USD -118.50M 2017-01-01 2017-12-31 2019 FY 10-K 2020-02-28 0001193125-20-056733
us-gaap IncreaseDecreaseInRestrictedCash Increase (Decrease) in Restricted Cash USD -5.05M 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-01 0001193125-18-067079
us-gaap IncrementalCommonSharesAttributableToShareBasedPaymentArrangements Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements shares 400,323 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap IndefiniteLivedIntangibleAssets Indefinite-lived Intangible Assets (Deprecated 2012-01-31) USD 595.49M 2011-12-31 2011 FY 10-K 2012-02-28 0001193125-12-085636
us-gaap IndefiniteLivedIntangibleAssetsAcquiredDuringPeriod Indefinite-lived Intangible Assets, Acquired During Period (Deprecated 2013-01-31) USD 23.77M 2011-01-01 2011-12-31 2011 FY 10-K 2012-02-28 0001193125-12-085636
us-gaap InterestExpense Interest Expense USD 415.01M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap InterestPaid Interest Paid, Including Capitalized Interest, Operating and Investing Activities USD 84.04M 2018-01-01 2018-06-30 2018 Q2 10-Q 2018-08-08 0001193125-18-242726
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 371.77M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap InvestmentAdvisoryFees Investment Advisory Fees (Deprecated 2018-01-31) USD 728.85M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-08 0001193125-18-155958
us-gaap InvestmentIncomeInterestAndDividend Investment Income, Interest and Dividend USD 368.11M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap InvestmentIncomeNet Investment Income, Net USD 7.96M 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-01 0001193125-19-061011
us-gaap Investments Investments USD 33.85B 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap InvestmentsFairValueDisclosure Investments, Fair Value Disclosure USD 1.05B 2019-12-31 2020 Q1 10-Q 2020-05-08 0001193125-20-137560
us-gaap LaborAndRelatedExpense Labor and Related Expense USD 4.62B 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap LeaseCost Lease, Cost USD 177.87M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-082531
us-gaap LesseeOperatingLeaseDiscountRate Lessee, Operating Lease, Discount Rate pure 0.035 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-082531
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 879.49M 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-082531
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 231.24M 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-082531
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 160.65M 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-082531
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 62.17M 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-082531
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 120.75M 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-082531
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 147.78M 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-082531
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 156.89M 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-082531
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 20.53M 2019-09-30 2019 Q3 10-Q 2019-11-08 0001193125-19-288342
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 18.47M 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-082531
us-gaap LettersOfCreditOutstandingAmount Letters of Credit Outstanding, Amount USD 700,000 2013-12-31 2013 FY 10-K 2014-02-28 0001193125-14-077145
us-gaap Liabilities Liabilities USD 28.62B 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 49.64B 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap LiabilitiesFairValueDisclosure Financial and Nonfinancial Liabilities, Fair Value Disclosure USD 6.65B 2019-03-31 2019 Q1 10-Q 2019-05-09 0001193125-19-142951
us-gaap LimitedPartnersCapitalAccount Limited Partners' Capital Account USD 6.42B 2018-12-31 2019 FY 10-K 2020-02-28 0001193125-20-056733
us-gaap LimitedPartnersCapitalAccountDistributionAmount Limited Partners' Capital Account, Distribution Amount USD -279.22M 2012-01-01 2012-03-31 2012 Q1 10-Q 2012-05-07 0001193125-12-215062
us-gaap LimitedPartnersCapitalAccountUnitsIssued Limited Partners' Capital Account, Units Issued shares 649.35M 2017-03-31 2017 Q1 10-Q 2017-05-09 0001193125-17-164159
us-gaap LimitedPartnersCapitalAccountUnitsOutstanding Limited Partners' Capital Account, Units Outstanding shares 649.35M 2017-03-31 2017 Q1 10-Q 2017-05-09 0001193125-17-164159
us-gaap LineOfCredit Long-term Line of Credit USD 12.58B 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-082531
us-gaap LineOfCreditFacilityAmountOutstanding Line of Credit Facility, Amount Outstanding (Deprecated 2014-01-31) USD 11.48B 2013-12-31 2013 FY 10-K 2014-02-28 0001193125-14-077145
us-gaap LineOfCreditFacilityCurrentBorrowingCapacity Line of Credit Facility, Current Borrowing Capacity USD 1.02B 2011-09-30 2011 Q3 10-Q 2011-11-09 0001193125-11-304545
us-gaap LineOfCreditFacilityMaximumBorrowingCapacity Line of Credit Facility, Maximum Borrowing Capacity USD 2.25M 2020-12-31 2020 FY 10-K 2021-02-26 0001193125-21-060361
us-gaap LitigationSettlementExpense Litigation Settlement, Expense USD 18.00M 2026-10-01 2026-10-31 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap LoansPayable Loans Payable USD 13.40B 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap LoansReceivableFairValueDisclosure Loans Receivable, Fair Value Disclosure USD 130.37M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap LongTermDebt Long-term Debt USD 13.52B 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive Long-Term Debt, Maturity, after Year Five USD 8.37B 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths Long-Term Debt, Maturity, Year One USD 750.14M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive Long-Term Debt, Maturity, Year Five USD 1.80B 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour Long-Term Debt, Maturity, Year Four USD 844.22M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree Long-Term Debt, Maturity, Year Three USD 720.34M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo Long-Term Debt, Maturity, Year Two USD 1.04B 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear Long-Term Debt, Maturity, Remainder of Fiscal Year USD 0 2018-09-30 2018 Q3 10-Q 2018-11-07 0001193125-18-320873
us-gaap LossContingencyAccrualAtCarryingValue Loss Contingency Accrual USD 1.46B 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap LossContingencyAccrualCarryingValuePeriodIncreaseDecrease Loss Contingency Accrual, Period Increase (Decrease) USD 1.46B 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap LossContingencyAccrualPayments Loss Contingency Accrual, Payments USD 52.30M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-082531
us-gaap LossContingencyEstimateOfPossibleLoss Loss Contingency, Estimate of Possible Loss USD 9.00B 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap MinorityInterestDecreaseFromRedemptions Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests USD 135.61M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap MinorityInterestInNetIncomeLossLimitedPartnerships Net Income (Loss) Attributable to Noncontrolling Interest, Limited Partnerships (Deprecated 2013-01-31) USD -58.33M 2012-01-01 2012-03-31 2012 Q1 10-Q 2012-05-07 0001193125-12-215062
us-gaap MinorityInterestInOperatingPartnerships Noncontrolling Interest in Operating Partnerships USD 4.83B 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD -4.37B 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD 266.79M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-08 0001193125-18-155958
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -111.34M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Provided by (Used in) Investing Activities, Continuing Operations USD -4.69M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-08 0001193125-18-155958
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD 4.90B 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD -1.77B 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-08 0001193125-18-155958
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD 2.54B 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap NetIncomeLossAllocatedToGeneralPartners Net Income (Loss) Allocated to General Partners USD 405.46M 2020-04-01 2020-06-30 2021 Q2 10-Q 2021-08-06 0001193125-21-239233
us-gaap NetIncomeLossAttributableToNoncontrollingInterest Net Income (Loss) Attributable to Noncontrolling Interest USD -154.22M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-08 0001193125-18-155958
us-gaap NetIncomeLossAttributableToParentDiluted Net Income (Loss) Attributable to Parent, Diluted USD 3.06B 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-06 0001193125-21-239233
us-gaap NetIncomeLossAttributableToRedeemableNoncontrollingInterest Net Income (Loss) Attributable to Redeemable Noncontrolling Interest USD 29.65M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest USD 4.86B 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap NetInvestmentHedgeDerivativeAssetsAtFairValue Derivative Instruments in Hedges, Net Investment in Foreign Operations, Assets, Fair Value USD 29,000 2017-09-30 2017 Q3 10-Q 2017-11-07 0001193125-17-335723
us-gaap NetInvestmentHedgeDerivativeLiabilitiesAtFairValue Derivative Instruments in Hedges, Net Investment in Foreign Operations, Liabilities, Fair Value USD 1,000 2015-12-31 2016 FY 10-K 2017-02-24 0001193125-17-056300
us-gaap NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification (Deprecated 2020-01-31) USD -7.05M 2016-01-01 2016-12-31 2018 FY 10-K 2019-03-01 0001193125-19-061011
us-gaap NoncashOrPartNoncashAcquisitionPayablesAssumed1 Noncash or Part Noncash Acquisition, Payables Assumed USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-02-26 0001193125-21-060361
us-gaap NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1 Noncash or Part Noncash Divestiture, Amount of Consideration Received USD 311.83M 2015-01-01 2015-12-31 2017 FY 10-K 2018-03-01 0001193125-18-067079
us-gaap NoncontrollingInterestDecreaseFromDeconsolidation Noncontrolling Interest, Decrease from Deconsolidation USD 2.24M 2020-01-01 2020-03-31 2020 Q1 10-Q 2020-05-08 0001193125-20-137560
us-gaap NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest Noncontrolling Interest, Increase from Sale of Parent Equity Interest USD 185.98M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap NonredeemableNoncontrollingInterest Nonredeemable Noncontrolling Interest USD 5.92B 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap NotesPayableFairValueDisclosure Notes Payable, Fair Value Disclosure USD 244,000 2020-12-31 2020 FY 10-K 2021-02-26 0001193125-21-060361
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 4 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 4 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap OperatingExpenses Operating Expenses USD 3.02B 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-07 0001193125-18-320873
us-gaap OperatingLeaseCost Operating Lease, Cost USD 149.49M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-082531
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 792.39M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap OperatingLeasePayments Operating Lease, Payments USD 187.01M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-082531
us-gaap OperatingLeasePaymentsUse Operating Lease, Payments, Use USD 41.69M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-082531
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 723.12M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 661.30M 2018-12-31 2019 FY 10-K 2020-02-28 0001193125-20-056733
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 78.51M 2018-12-31 2019 FY 10-K 2020-02-28 0001193125-20-056733
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 77.25M 2018-12-31 2019 FY 10-K 2020-02-28 0001193125-20-056733
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 79.09M 2018-12-31 2019 FY 10-K 2020-02-28 0001193125-20-056733
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 80.91M 2018-12-31 2019 FY 10-K 2020-02-28 0001193125-20-056733
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 72.19M 2018-12-31 2019 FY 10-K 2020-02-28 0001193125-20-056733
us-gaap OperatingLeasesFutureMinimumPaymentsDueThereafter Operating Leases, Future Minimum Payments, Due Thereafter USD 273.35M 2018-12-31 2019 FY 10-K 2020-02-28 0001193125-20-056733
us-gaap OperatingLeasesRentExpenseNet Operating Leases, Rent Expense, Net USD 109.90M 2018-01-01 2018-12-31 2020 FY 10-K 2021-02-26 0001193125-21-060361
us-gaap OperatingLossCarryforwards Operating Loss Carryforwards USD 0 2023-12-31 8-K 2024-11-25 0001193125-24-264461
us-gaap OtherAssets Other Assets USD 1.02B 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap OtherAssetsMiscellaneous Other Assets, Miscellaneous USD 55.58M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax (Deprecated 2012-01-31) USD -2.17M 2012-01-01 2012-03-31 2012 Q1 10-Q 2012-05-07 0001193125-12-215062
us-gaap OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax USD -54.79M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent Other Comprehensive Income (Loss), before Tax, Portion Attributable to Parent USD 415.46M 2012-01-01 2012-03-31 2012 Q1 10-Q 2012-05-07 0001193125-12-215062
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax USD -22.72M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap OtherIncome Other Income USD -2.48M 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-05 0001193125-15-368290
us-gaap OtherInvestments Other Investments USD 2.20B 2021-11-02 2022 Q2 10-Q 2022-08-05 0001193125-22-213575
us-gaap OtherLiabilities Other Liabilities USD 3.90B 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap OtherNoncashIncomeExpense Other Noncash Income (Expense) USD 387.64M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap OtherNonoperatingGainsLosses Other Nonoperating Gains (Losses) USD 333.26M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap OtherNonoperatingIncome Other Nonoperating Income USD 49.84M 2016-01-01 2016-06-30 2016 Q2 10-Q 2016-08-04 0001193125-16-671763
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 333.26M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap OtherOperatingIncomeExpenseNet Other Operating Income (Expense), Net USD 74.66M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap OtherReceivables Other Receivables USD 6.50B 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap PartnersCapital Partners' Capital USD 6.31B 2019-06-30 2019 Q2 10-Q 2019-08-08 0001193125-19-216805
us-gaap PartnersCapitalAccountContributions Partners' Capital Account, Contributions USD 987.43M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap PartnersCapitalAccountDistributions Partners' Capital Account, Distributions USD 6.09B 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap PartnersCapitalAccountRedemptions Partners' Capital Account, Redemptions USD 142.22M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap PartnersCapitalAccountTreasuryUnitsPurchases Partners' Capital Account, Treasury Units, Purchased USD 75.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap PartnersCapitalAccountUnitBasedCompensation Partners' Capital Account, Unit-based Payment Arrangement, Amount USD 1.27B 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap PartnersCapitalAccountUnits Partners' Capital Account, Units shares 693.61M 2021-09-30 2022 Q3 10-Q 2022-11-04 0001193125-22-277894
us-gaap PartnersCapitalAccountUnitsRedeemed Partners' Capital Account, Units, Redeemed shares 3.80M 2021-01-01 2021-09-30 2022 Q3 10-Q 2022-11-04 0001193125-22-277894
us-gaap PartnersCapitalAccountUnitsTreasury Partners' Capital Account, Units, Treasury Units Purchased shares 6.05M 2021-01-01 2021-09-30 2022 Q3 10-Q 2022-11-04 0001193125-22-277894
us-gaap PartnersCapitalAdjustedBalance1 Partners' Capital, Adjusted Balance (Deprecated 2020-01-31) USD 9.63M 2015-12-31 2017 FY 10-K 2018-03-01 0001193125-18-067079
us-gaap PartnersCapitalAttributableToNoncontrollingInterest Partners' Capital Attributable to Noncontrolling Interest USD 3.87B 2019-06-30 2019 Q2 10-Q 2019-08-08 0001193125-19-216805
us-gaap PartnersCapitalIncludingPortionAttributableToNoncontrollingInterest Partners' Capital, Including Portion Attributable to Noncontrolling Interest USD 19.59B 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap PaymentsOfCapitalDistribution Payments of Capital Distribution USD 1.18B 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-08-08 0001193125-19-216805
us-gaap PaymentsOfDividendsCommonStock Payments of Ordinary Dividends, Common Stock USD 5.13B 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap PaymentsOfDividendsMinorityInterest Payments of Ordinary Dividends, Noncontrolling Interest USD 1.09B 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap PaymentsToAcquireBusinessesNetOfCashAcquired Payments to Acquire Businesses, Net of Cash Acquired USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-082531
us-gaap PaymentsToAcquireInvestments Payments to Acquire Investments USD 1.72B 2015-01-01 2015-06-30 2015 Q2 10-Q 2015-08-06 0001193125-15-280954
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 111.34M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap PaymentsToMinorityShareholders Payments to Noncontrolling Interests USD 6,000 2014-01-01 2014-12-31 2016 FY 10-K 2017-02-24 0001193125-17-056300
us-gaap PerformanceFees Performance Fees (Deprecated 2018-01-31) USD 3.71B 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-01 0001193125-18-067079
us-gaap PledgedAssetsSeparatelyReportedSecuritiesPledgedAsCollateralAtFairValue Pledged Assets Separately Reported, Securities Pledged as Collateral, at Fair Value USD 78.40M 2022-03-31 2022 Q1 10-Q 2022-05-05 0001193125-22-142277
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-082531
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00B 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-082531
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2020-12-31 2020 FY 10-K 2021-02-26 0001193125-21-060361
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2020-12-31 2020 FY 10-K 2021-02-26 0001193125-21-060361
us-gaap PrepaidExpenseCurrentAndNoncurrent Prepaid Expense USD 238.92M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap ProceedsFromIssuanceOfLongTermDebt Proceeds from Issuance of Long-term Debt USD 2.47B 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap ProceedsFromLoans Proceeds from Loans USD 668.64M 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-08-08 0001193125-19-216805
us-gaap ProceedsFromMinorityShareholders Proceeds from Noncontrolling Interests USD 1.11B 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap ProceedsFromPaymentsForInSecuritiesSoldUnderAgreementsToRepurchase Proceeds from (Payments for) in Securities Sold under Agreements to Repurchase USD 19.41M 2017-01-01 2017-03-31 2017 Q1 10-Q 2017-05-09 0001193125-17-164159
us-gaap ProceedsFromRepaymentsOfNotesPayable Proceeds from (Repayments of) Notes Payable USD -155.81M 2011-01-01 2011-03-31 2011 Q1 10-Q 2011-05-06 0001193125-11-130720
us-gaap ProceedsFromSaleAndMaturityOfOtherInvestments Proceeds from Sale and Maturity of Other Investments USD 2.04B 2015-01-01 2015-06-30 2015 Q2 10-Q 2015-08-06 0001193125-15-280954
us-gaap ProceedsFromSaleMaturityAndCollectionsOfInvestments Proceeds from Sale, Maturity and Collection of Investments USD 3.63B 2015-01-01 2015-06-30 2015 Q2 10-Q 2015-08-06 0001193125-15-280954
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD 4.89B 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 1.05B 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 556.92M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap PropertyPlantAndEquipmentUsefulLifeMaximum Property, Plant and Equipment, Useful Life, Maximum (Deprecated 2012-01-31) years 7 2011-01-01 2011-12-31 2011 FY 10-K 2012-02-28 0001193125-12-085636
us-gaap PropertyPlantAndEquipmentUsefulLifeMinimum Property, Plant and Equipment, Useful Life, Minimum (Deprecated 2012-01-31) years 3 2011-01-01 2011-12-31 2011 FY 10-K 2012-02-28 0001193125-12-085636
us-gaap RedeemableNoncontrollingInterestEquityCarryingAmount Redeemable Noncontrolling Interest, Equity, Carrying Amount USD 1.43B 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap RedeemableNoncontrollingInterestEquityFairValue Redeemable Noncontrolling Interest, Equity, Fair Value USD 188.66M 2017-03-31 2017 Q1 10-Q 2017-05-09 0001193125-17-164159
us-gaap RelatedPartyTransactionAmountsOfTransaction Related Party Transaction, Amounts of Transaction USD 580.90M 2018-04-01 2018-06-30 2019 FY 10-K 2020-02-28 0001193125-20-056733
us-gaap RepaymentsOfLongTermDebt Repayments of Long-term Debt USD 1.45B 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap RestrictedCashAndCashEquivalents Restricted Cash and Cash Equivalents USD 14.46M 2017-12-31 2018 FY 10-K 2019-03-01 0001193125-19-061011
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -383.19M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap RetainedEarningsAppropriated Retained Earnings, Appropriated USD 81.30M 2014-12-31 2015 FY 10-K 2016-02-26 0001193125-16-481948
us-gaap RevenueFromRelatedParties Revenue from Related Parties USD 161.15M 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-01 0001193125-18-067079
us-gaap Revenues Revenues USD 11.72B 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap SalariesAndWages Salary and Wage, NonOfficer, Excluding Cost of Good and Service Sold USD 3.03B 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap SecuritiesForReverseRepurchaseAgreements Securities for Reverse Repurchase Agreements USD 0 2017-12-31 2017 FY 10-K 2018-03-01 0001193125-18-067079
us-gaap SecuritiesPurchasedUnderAgreementsToResell Securities Purchased under Agreements to Resell USD 118.50M 2016-12-31 2017 FY 10-K 2018-03-01 0001193125-18-067079
us-gaap SecuritiesPurchasedUnderAgreementsToResellAmountOffsetAgainstCollateral Securities Purchased under Agreements to Resell, Amount Offset Against Collateral USD 720,000 2016-12-31 2017 FY 10-K 2018-03-01 0001193125-18-067079
us-gaap SecuritiesPurchasedUnderAgreementsToResellCollateralObligationToReturnCash Securities Purchased under Agreements to Resell, Collateral, Obligation to Return Cash USD 0 2016-12-31 2017 FY 10-K 2018-03-01 0001193125-18-067079
us-gaap SecuritiesPurchasedUnderAgreementsToResellCollateralObligationToReturnSecurities Securities Purchased under Agreements to Resell, Collateral, Obligation to Return Securities USD 117.78M 2016-12-31 2017 FY 10-K 2018-03-01 0001193125-18-067079
us-gaap SecuritiesReceivedAsCollateralAmountRepledgedAndSold Securities Received as Collateral, Amount Repledged and Sold USD 68.80M 2016-01-01 2016-12-31 2017 FY 10-K 2018-03-01 0001193125-18-067079
us-gaap SecuritiesSoldUnderAgreementsToRepurchase Securities Sold under Agreements to Repurchase USD 89.94M 2022-12-31 8-K 2024-11-25 0001193125-24-264461
us-gaap SecuritiesSoldUnderAgreementsToRepurchaseAmountOffsetAgainstCollateral Securities Sold under Agreements to Repurchase, Amount Offset Against Collateral USD 0 2022-12-31 8-K 2024-11-25 0001193125-24-264461
us-gaap SecuritiesSoldUnderAgreementsToRepurchaseCollateralRightToReclaimCash Securities Sold under Agreements to Repurchase, Collateral, Right to Reclaim Cash USD 0 2022-12-31 8-K 2024-11-25 0001193125-24-264461
us-gaap SecuritiesSoldUnderAgreementsToRepurchaseCollateralRightToReclaimSecurities Securities Sold under Agreements to Repurchase, Collateral, Right to Reclaim Securities USD 89.94M 2022-12-31 8-K 2024-11-25 0001193125-24-264461
us-gaap SecuritiesSoldUnderAgreementsToRepurchaseGross Securities Sold under Agreements to Repurchase, Gross USD 311.21M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap SecuritiesSoldUnderAgreementsToRepurchaseNotSubjectToMasterNettingArrangement Securities Sold under Agreements to Repurchase, Not Subject to Master Netting Arrangement USD 0 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap SecurityOwnedAndSoldNotYetPurchasedFairValueSecuritySoldNotYetPurchased Security Owned and Sold, Not yet Purchased Fair Value, Security Sold, Not yet Purchased USD 178.45M 2017-03-31 2017 Q1 10-Q 2017-05-09 0001193125-17-164159
us-gaap SeniorNotes Senior Notes USD 600.00M 2012-12-31 2017 FY 10-K 2018-03-01 0001193125-18-067079
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 1.25B 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsTotalShareBasedLiabilitiesPaid Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Share-based Liabilities Paid (Deprecated 2014-01-31) USD 600,000 2013-12-31 2013 FY 10-K 2014-02-28 0001193125-14-077145
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 1.24B 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 8.84B 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD 19.59B 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap StockholdersEquityNoteSpinoffTransaction Stockholders' Equity Note, Spinoff Transaction USD -367.24M 2015-01-01 2015-12-31 2017 FY 10-K 2018-03-01 0001193125-18-067079
us-gaap StockIssued1 Stock Issued USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-02-26 0001193125-21-060361
us-gaap StockIssuedDuringPeriodSharesConversionOfUnits Stock Issued During Period, Shares, Conversion of Units shares 11.98M 2021-01-01 2021-09-30 2022 Q3 10-Q 2022-11-04 0001193125-22-277894
us-gaap StockRepurchasedDuringPeriodShares Stock Repurchased During Period, Shares shares 8.50M 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-08-08 0001193125-19-216805
us-gaap StockRepurchasedDuringPeriodValue Stock Repurchased During Period, Value USD 343.10M 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-08-08 0001193125-19-216805
us-gaap StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount Stock Repurchase Program, Remaining Authorized Repurchase Amount (Deprecated 2014-01-31) USD 335.80M 2014-01-01 2014-03-31 2014 Q1 10-Q 2014-05-08 0001193125-14-190051
us-gaap StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1 Stock Repurchase Program, Remaining Authorized Repurchase Amount USD 1.60B 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap SubleaseIncome Sublease Income USD 206,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-082531
us-gaap TaxCreditCarryforwardAmount Tax Credit Carryforward, Amount USD 0 2018-12-31 2018 FY 10-K 2019-03-01 0001193125-19-061011
us-gaap TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxExpenseBenefit Tax Cuts and Jobs Act, Change in Tax Rate, Income Tax Expense (Benefit) USD 500.60M 2017-01-01 2017-12-31 2020 FY 10-K 2021-02-26 0001193125-21-060361
us-gaap TemporaryEquityForeignCurrencyTranslationAdjustments Temporary Equity, Foreign Currency Translation Adjustments USD 32.07M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap UndistributedEarningsDiluted Undistributed Earnings, Diluted USD -1.07B 2009-01-01 2009-12-31 2011 FY 10-K 2012-02-28 0001193125-12-085636
us-gaap UnitsOfPartnershipInterestAmount Units of Partnership Interest, Amount shares 176.60M 2026-01-01 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap UnrealizedGainLossOnDerivatives Unrealized Gain (Loss) on Derivatives USD 15.20M 2017-01-01 2017-06-30 2017 Q2 10-Q 2017-08-08 0001193125-17-251308
us-gaap UnrealizedGainLossOnDerivativesAndCommodityContracts Unrealized Gain (Loss) on Derivatives and Commodity Contracts USD -20.82M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap UnrealizedGainLossOnInvestments Unrealized Gain (Loss) on Investments USD 487.13M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 315.60M 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-082531
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Decrease Resulting from Current Period Tax Positions USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-082531
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-082531
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities USD 471,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-082531
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued Unrecognized Tax Benefits, Income Tax Penalties Accrued USD 0 2021-12-31 2021 FY 10-K 2022-02-25 0001193125-22-054433
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued USD 500,000 2012-12-31 2012 FY 10-K 2013-03-01 0001193125-13-087702
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 59.88M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-082531
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions USD 4.40M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-082531
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities Unrecognized Tax Benefits, Increase Resulting from Settlements with Taxing Authorities USD -1.60M 2012-01-01 2012-12-31 2012 FY 10-K 2013-03-01 0001193125-13-087702
us-gaap UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued Unrecognized Tax Benefits, Interest on Income Taxes Accrued USD -400,000 2015-12-31 2015 FY 10-K 2016-02-26 0001193125-16-481948
us-gaap UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations USD 3.77M 2016-01-01 2016-12-31 2018 FY 10-K 2019-03-01 0001193125-19-061011
us-gaap UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate Unrecognized Tax Benefits that Would Impact Effective Tax Rate USD 153.60M 2022-12-31 2022 FY 10-K 2023-02-24 0001193125-23-048733
us-gaap UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount Unrecorded Unconditional Purchase Obligation USD 15.90M 2020-12-31 2020 FY 10-K 2021-02-26 0001193125-21-060361
us-gaap VariableInterestEntityEntityMaximumLossExposureAmount Variable Interest Entity, Reporting Entity Involvement, Maximum Loss Exposure, Amount USD 814.95M 2017-03-31 2017 Q1 10-Q 2017-05-09 0001193125-17-164159
us-gaap VariableInterestEntityNonconsolidatedCarryingAmountAssets Variable Interest Entity, Nonconsolidated, Carrying Amount, Assets (Deprecated 2020-01-31) USD 730.65M 2017-03-31 2017 Q1 10-Q 2017-05-09 0001193125-17-164159
us-gaap VariableInterestEntityNonconsolidatedCarryingAmountLiabilities Variable Interest Entity, Nonconsolidated, Carrying Amount, Liabilities (Deprecated 2020-01-31) USD 1.21M 2012-09-30 2012 Q3 10-Q 2012-11-02 0001193125-12-449159
us-gaap VariableLeaseCost Variable Lease, Cost USD 28.58M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-082531
us-gaap WeightedAverageGeneralPartnershipUnitsOutstanding Weighted Average General Partnership Units Outstanding shares 505.75M 2020-04-01 2020-06-30 2021 Q2 10-Q 2021-08-06 0001193125-21-239233
us-gaap WeightedAverageLimitedPartnershipUnitsOutstandingDiluted Weighted Average Limited Partnership Units Outstanding, Diluted shares 288.99M 2009-01-01 2009-12-31 2011 FY 10-K 2012-02-28 0001193125-12-085636
us-gaap WeightedAverageNumberDilutedSharesOutstandingAdjustment Weighted Average Number Diluted Shares Outstanding Adjustment shares 364.02M 2010-01-01 2010-12-31 2010 FY 10-K 2011-02-25 0001193125-11-047389
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 795.44M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 795.04M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451802
us-gaap WeightedAverageNumberOfSharesOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted (Deprecated 2012-01-31) shares 475.58M 2011-12-31 2011 FY 10-K 2012-02-28 0001193125-12-085636

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →